Abstract: An apparatus for controlling access to a data memory is provided. The apparatus includes an input interface configured to receive a request from an external processor circuit for accessing a memory area of the data memory. The apparatus additionally includes a control circuit configured to determine whether the memory area is to be accessed exclusively from within a trusted execution environment. Further, if it is determined that the memory area is to be accessed exclusively from within the trusted execution environment, the control circuit is configured to control access to the memory area of the data memory based on security information indicating whether the external processor circuit is operating in a secure mode related to the trusted execution environment.

Abstract: A method for testing a Device Under Test (DUT) is provided. The method includes emulating a Trusted Execution Environment (TEE) of the DUT by means of a software emulator in order to provide an emulated TEE. The method further comprises intercepting at the DUT a call from a Rich Execution Environment (REE) of the DUT into the TEE of the DUT. In addition, the method includes transmitting the call to the emulated TEE such that the call is processed by the emulated TEE. The method includes transmitting a response of the emulated TEE to the REE. The response is based on the call.

Abstract: An apparatus for controlling access to a data memory is provided. The apparatus includes an input interface configured to receive a request from an external processor circuit for accessing a memory area of the data memory. The apparatus additionally includes a control circuit configured to determine whether the memory area is to be accessed exclusively from within a trusted execution environment. Further, if it is determined that the memory area is to be accessed exclusively from within the trusted execution environment, the control circuit is configured to control access to the memory area of the data memory based on security information indicating whether the external processor circuit is operating in a secure mode related to the trusted execution environment.

Abstract: A data processing apparatus comprising processor circuitry, the processor circuitry being configured: to determine whether a decision associated with a process executable by the processor circuitry is to be made; in response to determining that the decision is to be made, to determine one of a plurality of predetermined actions to be executed based on a previously indicated action executable in response to the decision to be made at the data processing apparatus or at one or more other data processing apparatuses connected to the data processing apparatus; and to execute the determined predetermined action.

Abstract: A method comprising partitioning a space of user requests into subsets, and determining a risk score for a user request based on the evolution of the number of user requests in the subset of user requests to which this user request belongs.

Abstract: A method comprising partitioning a space of user requests into subsets, and determining a risk score for a user request based on the evolution of the number of user requests in the subset of user requests to which this user request belongs.

Abstract: Disclosed herein are immunoconjugates comprising an inhibitor of Eg5 linked to an antigen binding moiety such as an antibody, that are useful for treating cell proliferative disorders. Also disclosed are novel inhibitors of Eg5 that can be used either alone or as part of an immunoconjugate to treat cell proliferation disorders. The Eg5 inhibitors include compounds of this formula as described herein: The invention further provides pharmaceutical compositions comprising these compounds and immunoconjugates, and compositions comprising the immunoconjugates or compounds with a therapeutic co-agent, and methods to use these compounds, conjugates and compositions for treating cell proliferation disorders.

Abstract: Disclosed herein are immunoconjugates comprising an inhibitor of Eg5 linked to an antigen binding moiety such as an antibody, that are useful for treating cell proliferative disorders. Also disclosed are novel inhibitors of Eg5 that can be used either alone or as part of an immunoconjugate to treat cell proliferation disorders. The Eg5 inhibitors include compounds of this formula as described herein: The invention further provides pharmaceutical compositions comprising these compounds and immunoconjugates, and compositions comprising the immunoconjugates or compounds with a therapeutic co-agent, and methods to use these compounds, conjugates and compositions for treating cell proliferation disorders.